Figure 1.
Kaplan-Meier survival. A: Kaplan-Meier overall survival for transarterial chemoembolization (TACE) alone and TACE + sorafenib; B: Kaplan-Meier progression-free survival for TACE alone and TACE + sorafenib.
Kaplan-Meier survival. A: Kaplan-Meier overall survival for transarterial chemoembolization (TACE) alone and TACE + sorafenib; B: Kaplan-Meier progression-free survival for TACE alone and TACE + sorafenib.